Open AccessSeven-day triple therapy is a better choice forHelicobacter pylorieradication in regions with low antibiotic resistance
Author(s) -
Yue-Feng Tong,
Jun Lee,
Li-Yuan Ying,
Fei Xu,
Bo Qin,
Mingtong Chen,
Fei Meng,
Miaoying Tu,
Ning Yang,
Youming Li,
Jianzhong Zhang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13073
Subject(s) - levofloxacin , clarithromycin , amoxicillin , helicobacter pylori , medicine , antibiotics , antibiotic resistance , gastroenterology , agar dilution , breath test , urea breath test , microbiology and biotechnology , helicobacter pylori infection , minimum inhibitory concentration , biology
To investigate whether 7-d triple therapies are still valid in populations with low levels of resistance.